Prior to February 2024, limited therapeutics were available to treat sepsis, a life threatening organ dysfunction caused by a dysregulated host response to infection. Now, a new, commercially viable method of treatment is ...
Apr 13, 2024
0
1
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
2
Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams with pictures taken by a retinal ...
Apr 5, 2024
0
0
A Louisville, Colorado, company is studying whether cells taken from patients' fat could reduce knee pain and improve motion in people with arthritis.
Mar 27, 2024
0
8
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday.
Mar 22, 2024
0
12
A Cornell doctoral student is building a company based on a radio-based technology that could sense cardiac and respiratory troubles for patients without the need for them to wear a bulky monitor or skin electrodes. SensVita, ...
Mar 18, 2024
0
0
The use of melatonin supplements as a sleep aid for children is becoming more common. The number of children taking melatonin at least once a month has risen nearly 20-fold since 2018. From 2012 to 2021, calls to poison control ...
Mar 12, 2024
0
0
Drug approvals in the United States between 2010–2019 were aligned with the US, but not global, burden of disease and the increasing number of expedited drug approvals could make the gap worse according to a study in the ...
Mar 12, 2024
0
0
Human safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall.
Feb 29, 2024
0
1
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
Feb 24, 2024
0
1
